The Diagnosis, Assessment and Treatment of Diffuse Parenchymal Lung Disease in Adults

April 1999
Thorax;Apr1999 Supp, Vol. 54, pS1
Academic Journal
No abstract available.


Related Articles

  • CHAPTER 7: Diffuse parenchymal lung disease. Scullion, Jane E. // Fundamental Aspects of Nursing Adults with Respiratory Disorders;2007, p81 

    Chapter 7 of the book "Fundamental Aspects of Nursing Adults With Respiratory Disorders" is presented. It provides an overview of the diffuse parenchymal lung disease, a broad category of lung diseases including asbestosis, chronic hypersensitivity pneumonia and silicosis. It also discusses the...

  • The Respiratory Therapist's Role in Recognizing Pulmonary Fibrosis. Kervitsky, Dolly (Alma) J. // AARC Times;Jun2015, Vol. 39 Issue 6, p6 

    The article discusses the diagnosis, prognosis and treatment of the lung disease called pulmonary fibrosis (PF) and the role of respiratory therapists in identifying PF. It claims that PF occurs in many interstitial lung diseases (ILD) or diffuse parenchymal lung disease (DPLD). Also cited are...

  • Quantitative Stratification of Diffuse Parenchymal Lung Diseases. Raghunath, Sushravya; Rajagopalan, Srinivasan; Karwoski, Ronald A.; Maldonado, Fabien; Peikert, Tobias; Moua, Teng; Ryu, Jay H.; Bartholmai, Brian J.; Robb, Richard A. // PLoS ONE;Mar2014, Vol. 9 Issue 3, p1 

    Diffuse parenchymal lung diseases (DPLDs) are characterized by widespread pathological changes within the pulmonary tissue that impair the elasticity and gas exchange properties of the lungs. Clinical-radiological diagnosis of these diseases remains challenging and their clinical course is...

  • Pulmonary Hypertension in Parenchymal Lung Disease. Tsangaris, Iraklis; Tsaknis, Georgios; Anthi, Anastasia; Orfanos, Stylianos E. // Pulmonary Medicine;2012, p1 

    Idiopathic pulmonary arterial hypertension (IPAH) has been extensively investigated, although it represents a less common form of the pulmonary hypertension (PH) family, as shown by international registries. Interestingly, in types of PH that are encountered in parenchymal lung diseases such as...

  • Diffuse Parenchymal Lung Diseases with Clinicoradiological Discordance-: Role of Transbronchial Lung Biopsy as a Diagnostic Tool - An Observational Study. SURAJ, K. P.; NARAYAN, KIRAN VISHNU; EDAKALAVAN, JYOTHI; KUMAR, NEETHU KESAVA // Journal of Clinical & Diagnostic Research;Nov2016, Vol. 10 Issue 11, p1 

    Introduction: The diagnosis of Diffuse Parenchymal Lung Disease (DPLD) requires a multidisciplinary approach with reconciliation of clinicoradiological and histopathological data. But when the preliminary clinicoradiological profile fails to suggest a diagnosis, an adequate lung biopsy specimen...

  • Computer- Aided diagnosis system for the evaluation of chronic obstructive pulmonary disease on CT Images. Hosseini, Mohammad Parsa; Soltanian-Zadeh, Hamid; Akhlaghpoor, Shahram // Tehran University Medical Journal;Mar2011, Vol. 68 Issue 12, p718 

    Background: Chronic Obstructive Pulmonary Disease (COPD) is one of the most prevalent pulmonary diseases. Use of an automatic system for the detection and diagnosis of the disease will be beneficial to the patients' treatment decision-making process. In this paper, we propose a new approach for...

  • Shrinking lung syndrome complicating pediatric systemic lupus erythematosus. Burns, Natalie; Stevens, Anne; Iyer, Ramesh // Pediatric Radiology;Oct2014, Vol. 44 Issue 10, p1318 

    Systemic lupus erythematosis (SLE) can affect the lungs and pleura, usually manifesting with pleural effusions or diffuse parenchymal disease. A rare manifestation of SLE is shrinking lung syndrome, a severe restrictive respiratory disorder. While pleuropulmonary complications of pediatric SLE...

  • Histopathology and Exercise: A Winning Combination in Pulmonary Fibrosis: A Case Report. Pisano, Viviana; Fuschillo, Salvatore; Balzano, Giovanni // Respiratory Care;Mar2014, Vol. 59 Issue 3, pe31 

    The diffuse parenchymal lung diseases form a heterogeneous group of disorders characterized by varying degrees of inflammation and fibrosis involving the space between epithelial and endothelial basement membranes. Among the diffuse parenchymal lung diseases of unknown etiology, one of the most...

  • CHAPTER 6: Lung cancer. Darlison, Liz // Fundamental Aspects of Nursing Adults with Respiratory Disorders;2007, p71 

    Chapter 6 of the book "Fundamental Aspects of Nursing Adults With Respiratory Disorders" is presented. It focuses on lung cancer. It discusses information on the disease's causes, symptoms, and diagnosis and treatment. It also discusses the various types and stages of lung cancer. Research on...

  • Beneficial effect of treatment with cyclosporin A in a case of refractory antisynthetase syndrome. Jankowska, Magdalena; Butto, Barbara; Dębska-Ślizień, Alicja; Rutkowski, Bolesław // Rheumatology International;Jun2007, Vol. 27 Issue 8, p775 

    We report a case of idiopathic inflammatory myopathy accompanied with the presence of anti-Jo1 antibodies and complicated by diffuse parenchymal lung disease (antisynthetase syndrome). Efficacy of different therapeutic agents, including corticosteroids, cyclophosphamide and cyclosporin A, is...


Read the Article


Sign out of this library

Other Topics